Tomosynthesis Market Penetration On the heels of a very successful RSNA 2021, a major milestone has been reached. For the first time, the number of tomosynthesis-capable mammography systems in the United States exceeds 80% of the installed base. In the latest MQSA statistics, the FDA reported that of 13,147 distinct X-ray units, 10,537 (80.1%) are […]

Information Silos Hamper Service​ Ever hear of the Information Age? According to Wikipedia, it is “a historical period that began in the mid-20th century, characterized by a rapid epochal shift from traditional industry established by the Industrial Revolution to an economy primarily based upon information technology”. I think we can all agree with that – […]

Mammography Level 2 Violations In March 2018, the US FDA implemented a rule called “Enhancing Quality Using the Inspection Program” (EQUIP), which added new, important requirements for mammography providers beyond those of the original Mammography Quality MQSA. Compliance with EQUIP requirements was to be assessed during each MQSA inspection. The consequence of failing to meet […]